Sigilon Revenue and Competitors
Estimated Revenue & Valuation
- Sigilon's estimated annual revenue is currently $11.4M per year.
- Sigilon's estimated revenue per employee is $113,700
- Sigilon's total funding is $263.2M.
- Sigilon's current valuation is $68.5M. (January 2022)
- Sigilon has 100 Employees.
- Sigilon grew their employee count by -32% last year.
Sigilon Competitors & Alternatives
|Competitor Name||Revenue||Number of Employees||Employee Growth||Total Funding||Valuation|
What Is Sigilon?
Harnessing the full power of cell therapeutics. Cambridge, MAkeywords:N/A
Number of Employees
Employee Growth %
Sigilon Therapeutics, Inc. (NASDAQ:SGTX) Given Consensus Rating of Buy by Brokerages. Posted by admin on Apr 22nd, 2022.
The market has been high on Sigilon Therapeutics Inc (SGTX) stock recently. SGTX gets a Bullish score from InvestorsObserver Stock Sentiment...
Sigilon Therapeutics seeks to develop functional cures for patients with a broad range of chronic diseases by harnessing the power of the human...
|Company Name||Revenue||Number of Employees||Employee Growth||Total Funding|